Jianfeng Guo

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Journal: Molecular cell
Published: July 24, 2025

Survival after laparoscopic radical surgery for stage IA-IIB cervical cancer: 1316 consecutive cases from a national laparoscopic training center in China.

Survival after laparoscopic radical surgery for stage IA-IIB cervical cancer: 1316 consecutive cases from a national laparoscopic training center in China.

Journal: International journal of clinical oncology
Published: July 22, 2022

Resumption of the treatment of non-COVID-19 gynecologic patients after lifting lockdown: Triage and infection prevention experiences from Wuhan.

Resumption of the treatment of non-COVID-19 gynecologic patients after lifting lockdown: Triage and infection prevention experiences from Wuhan.

Journal: The journal of obstetrics and gynaecology research
Published: March 17, 2021

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer.

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer.

Journal: PeerJ
Published: December 21, 2020

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.

Journal: Frontiers in oncology
Published: September 14, 2020

HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis.

HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis.

Journal: Experimental cell research
Published: December 10, 2019

Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.

Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.

Journal: Molecular cancer research : MCR
Published: December 27, 2018

Laparoscopic procedure compared with open radical hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study.

Laparoscopic procedure compared with open radical hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study.

Journal: OncoTargets and therapy
Published: October 02, 2018

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

Journal: International journal of oncology
Published: November 23, 2017

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Journal: Molecular cell
Published: July 24, 2017

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo.

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo.

Journal: OncoTargets and therapy
Published: July 15, 2017

Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.

Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.

Journal: Oncotarget
Published: May 30, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026